Abstract
Introduction: This study presents the oral and maxillofacial pathological features of several types of odontogenic tumors in children and adolescents less than 18 years of age from a Bangladeshi tertiary-level healthcare facility. Materials and Methods: In this retrospective cross-sectional study, the World Health Organization (WHO) categorization for head and neck tumors in 2022 was used to assess the frequency of odontogenic tumors in children and adolescents. Data relating to sex, age, and tumor site were retrieved and presented. The Chi-square test was implemented to study the association between gender, age, and site with different types of odontogenic tumors. Results: A total of 106 cases were found, and all the cases were benign. Ameloblatoma (75.47%) was the most common tumor, followed by odontogenic myxoma (9.44%), cemento-ossifying fibroma (5.66%), and odontoma (4.72%). A male (60.38%) predominance was observed in the gender distribution, but no statistically noteworthy (P = 0.43) relationship was found. Most of the cases were found in the 13–18 age group (63.21%), with a mean age (standard deviation) of 13.01 (2.29) years. There was no statistical significance found between age group and tumor type (P = 0.78). The mandibular (95.28%) predominance was found over the maxilla (4.72%) (Mandible: Maxilla = 20.2:1) and was statistically significant (P= 0.002). In the mandible, the posterior region (88.68%) was mostly affected. Conclusions: Early detection of odontogenic tumors is rare, and as people aged, they become more common. Ameloblatoma was the most prevalent odontogenic tumor in the jaws, followed by odontogenic myxoma, cemento-ossifying fibroma, and odontoma. Adolescents experience odontogenic tumors more frequently than children do. The mandible was observed to predominate over the maxilla in terms of site distribution. The mandible's posterior portion was primarily affected. Update Dent. Coll. j: 2024; 14(1):19-23
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
